These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 15838109)

  • 1. Activins and inhibins and their signaling.
    Vale W; Wiater E; Gray P; Harrison C; Bilezikjian L; Choe S
    Ann N Y Acad Sci; 2004 Dec; 1038():142-7. PubMed ID: 15838109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.
    Lewis KA; Gray PC; Blount AL; MacConell LA; Wiater E; Bilezikjian LM; Vale W
    Nature; 2000 Mar; 404(6776):411-4. PubMed ID: 10746731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of inhibin binding to betaglycan, InhBP/p120 and the activin type II receptors.
    Chapman SC; Bernard DJ; Jelen J; Woodruff TK
    Mol Cell Endocrinol; 2002 Oct; 196(1-2):79-93. PubMed ID: 12385827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of activin and BMP signaling.
    Harrison CA; Wiater E; Gray PC; Greenwald J; Choe S; Vale W
    Mol Cell Endocrinol; 2004 Oct; 225(1-2):19-24. PubMed ID: 15451563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the mechanisms of activin action and inhibition.
    Walton KL; Makanji Y; Harrison CA
    Mol Cell Endocrinol; 2012 Aug; 359(1-2):2-12. PubMed ID: 21763751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular biology of inhibin action.
    Cook RW; Thompson TB; Jardetzky TS; Woodruff TK
    Semin Reprod Med; 2004 Aug; 22(3):269-76. PubMed ID: 15319829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rodent adrenocortical cells display high affinity binding sites and proteins for inhibin A, and express components required for autocrine signalling by activins and bone morphogenetic proteins.
    Farnworth PG; Wang Y; Leembruggen P; Ooi GT; Harrison C; Robertson DM; Findlay JK
    J Endocrinol; 2006 Mar; 188(3):451-65. PubMed ID: 16522726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in pituitary expression of mRNAs encoding the putative inhibin co-receptor (betaglycan) and type-I and type-II activin receptors during the chicken ovulatory cycle.
    Lovell TM; Knight PG; Gladwell RT
    J Endocrinol; 2005 Sep; 186(3):447-55. PubMed ID: 16135664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotrophins modulate hormone secretion and steady-state mRNA levels for activin receptors (type I, IIA, IIB) and inhibin co-receptor (betaglycan) in granulosa and theca cells from chicken prehierarchical and preovulatory follicles.
    Lovell TM; Al-Musawi SL; Gladwell RT; Knight PG
    Reproduction; 2007 Jun; 133(6):1159-68. PubMed ID: 17636170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibin is an antagonist of bone morphogenetic protein signaling.
    Wiater E; Vale W
    J Biol Chem; 2003 Mar; 278(10):7934-41. PubMed ID: 12493742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta modulates inhibin A bioactivity in the LbetaT2 gonadotrope cell line by competing for binding to betaglycan.
    Ethier JF; Farnworth PG; Findlay JK; Ooi GT
    Mol Endocrinol; 2002 Dec; 16(12):2754-63. PubMed ID: 12456797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betaglycan localization in the female rat pituitary: implications for the regulation of follicle-stimulating hormone by inhibin.
    Chapman SC; Woodruff TK
    Endocrinology; 2003 Dec; 144(12):5640-9. PubMed ID: 14500575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibins are the major activin ligands expressed during early thymocyte development.
    Licona P; Chimal-Monroy J; Soldevila G
    Dev Dyn; 2006 Apr; 235(4):1124-32. PubMed ID: 16477644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibins differentially antagonize activin and bone morphogenetic protein action in a mouse adrenocortical cell line.
    Farnworth PG; Stanton PG; Wang Y; Escalona R; Findlay JK; Ooi GT
    Endocrinology; 2006 Jul; 147(7):3462-71. PubMed ID: 16601134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI.
    Onichtchouk D; Chen YG; Dosch R; Gawantka V; Delius H; Massagué J; Niehrs C
    Nature; 1999 Sep; 401(6752):480-5. PubMed ID: 10519551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A molecular recognition paradigm: promiscuity associated with the ligand-receptor interactions of the activin members of the TGF-beta superfamily.
    Keah HH; Hearn MT
    J Mol Recognit; 2005; 18(5):385-403. PubMed ID: 15948132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activins bind and signal via bone morphogenetic protein receptor type II (BMPR2) in immortalized gonadotrope-like cells.
    Rejon CA; Hancock MA; Li YN; Thompson TB; Hébert TE; Bernard DJ
    Cell Signal; 2013 Dec; 25(12):2717-26. PubMed ID: 24018044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic protein 2 and activin A synergistically stimulate follicle-stimulating hormone beta subunit transcription.
    Lee KB; Khivansara V; Santos MM; Lamba P; Yuen T; Sealfon SC; Bernard DJ
    J Mol Endocrinol; 2007 Feb; 38(1-2):315-30. PubMed ID: 17293449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of betaglycan, an inhibin coreceptor, in normal human ovaries and ovarian sex cord-stromal tumors and its regulation in cultured human granulosa-luteal cells.
    Liu J; Kuulasmaa T; Kosma VM; Bützow R; Vänttinen T; Hydén-Granskog C; Voutilainen R
    J Clin Endocrinol Metab; 2003 Oct; 88(10):5002-8. PubMed ID: 14557487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonists of activin signaling: mechanisms and potential biological applications.
    Harrison CA; Gray PC; Vale WW; Robertson DM
    Trends Endocrinol Metab; 2005 Mar; 16(2):73-8. PubMed ID: 15734148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.